FDA Approved: IDAMYCIN PFS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for IDAMYCIN PFS (idarubicin hydrochloride) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• IDAMYCIN PFS (IDARUBICIN HYDROCHLORIDE)

Snippet

SUPPL AP for IDAMYCIN PFS (IDARUBICIN HYDROCHLORIDE)